Kelly D. Smith

Kelly D. Smith

Auto-generated profile, based on publicly available information

Kelly D. Smith

University of Washington

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2003 in Nature Immunology
Verified
Journal Article
Closed access
KSKelly D Smith
Kelly D Smith
EAErica Andersen-Nissen
Erica Andersen-Nissen
FHFumitaka Hayashi
Fumitaka Hayashi
KSKatie Strobe
Katie Strobe
MBMolly A Bergman
Molly A Bergman
AAAlan Aderem
Alan Aderem

31 October 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MFMichael A. Fischbach
Michael A. Fischbach
HLHening Lin
Hening Lin
LZLu Zhou
Lu Zhou
YYYang Yu
Yang Yu
RARebecca J. Abergel
Rebecca J. Abergel
KSKelly D. Smith
Kelly D. Smith
Numerous bacteria cope with the scarcity of iron in their microenvironment by synthesizing small iron-scavenging molecules known as siderophores. Mammals have evolved countermeasures to block siderophore-mediated iron acquisition as part of their innate immune response. Secreted lipocalin 2 (Lcn2) sequesters the Escherichia coli siderophore enterobactin (Ent), preventing E. coli from acquiring iron and protecting mammals from infection by E. coli . Here, we show that the iroA gene cluster, found in many pathogenic strains of Gram-negative enteric bacteria, including E. coli , Salmonella spp., and Klebsiella pneumoniae , allows bacteria to evade sequestration of Ent by Lcn2. We demonstrate that C-glucosylated derivatives of Ent produced by iroA -encoded enzymes do not bind purified Lcn2, and an iroA -harboring strain of E. coli is insensitive to the growth inhibitory effects of Lcn2 in vitro . Furthermore, we show that mice rapidly succumb to infection by an iroA -harboring strain of E. coli but not its wild-type counterpart, and that this increased virulence depends on evasion of host Lcn2. Our findings indicate that the iroA gene cluster allows bacteria to evade this component of the innate immune system, rejuvenating their Ent-mediated iron-acquisition pathway and playing an important role in their virulence.

1 January 2021 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
SAShreeram Akilesh
Shreeram Akilesh
CNCynthia C. Nast
Cynthia C. Nast
MYMichifumi Yamashita
Michifumi Yamashita
KHKammi Henriksen
Kammi Henriksen
VCVivek Charu
Vivek Charu
KSKelly D. Smith
Kelly D. Smith

2 November 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
NANicole K. Andeen
Nicole K. Andeen
HYHan-Yin Yang
Han-Yin Yang
DDDao-Fu Dai
Dao-Fu Dai
MMMichael J. MacCoss
Michael J. MacCoss
KSKelly D. Smith
Kelly D. Smith
Fibrillary GN is a rare form of GN of uncertain pathogenesis that is characterized by the glomerular accumulation of randomly arranged, nonbranching fibrils (12–24 nm) composed of Ig and complement proteins. In this study, we used mass spectrometry to comprehensively define the glomerular proteome in fibrillary GN compared with that in controls and nonfibrillary GN renal diseases. We isolated glomeruli from formalin-fixed and paraffin-embedded biopsy specimens using laser capture microdissection and analyzed them with liquid chromatography and data-dependent tandem mass spectrometry. These studies identified DnaJ homolog subfamily B member 9 (DNAJB9) as a highly sampled protein detected only in fibrillary GN cases. The glomerular proteome of fibrillary GN cases also contained IgG1 as the dominant Ig and proteins of the classic complement pathway. In fibrillary GN specimens only, immunofluorescence and immunohistochemistry with an anti-DNAJB9 antibody showed strong and specific staining of the glomerular tufts in a distribution that mimicked that of the immune deposits. Our results identify DNAJB9 as a putative autoantigen in fibrillary GN and suggest IgG1 and classic complement effector pathways as likely mediators of the destructive glomerular injury in this disease.

4 November 2019 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
NANicole K. Andeen
Nicole K. Andeen
MTMegan L. Troxell
Megan L. Troxell
MRMaziar Riazy
Maziar Riazy
RARupali S. Avasare
Rupali S. Avasare
JLJessica Lapasia
Jessica Lapasia
KSKelly D. Smith
Kelly D. Smith
Background and objectives: Fibrillary GN has been defined as an immune complex-mediated GN with amyloid-like fibrils larger than amyloid which are IgG positive and Congo red negative. With discovery of DNAJB9 as a highly sensitive and specific marker for fibrillary GN, the specificity of the morphologic criteria for establishing the diagnosis of fibrillary GN has come into question. Design, setting, participants, & measurements: We sought to (1) determine anatomic characteristics that best define fibrillary GN and (2) identify clinical and pathologic features that predict outcomes. Results: We retrospectively reviewed kidney biopsies from patients diagnosed with fibrillary GN or suspected fibrillary GN between 1997 and 2017 (n=266, 65% female, median age 61). Approximately 11% of kidney biopsies had one or more unusual feature including monotypic deposits, Congo red positivity, or unusual fibril diameter. Fibrillary GN as a possible monoclonal gammopathy of renal significance represented <1% of cases. Immunostaining for DNAJB9 confirmed fibrillary GN in 100% of cases diagnosed as fibrillary GN and 79% of atypical cases diagnosed as possible fibrillary GN. At a median time of 24 months (interquartile range, 8–46 months) after biopsy (n=100), 53% of patients reached the combined primary outcome of ESKD or death, 18% had CKD, and 18% had partial remission. On multivariable analysis, male sex (adjusted hazard ratio [aHR], 3.82; 95% confidence interval [95% CI], 1.97 to 7.37) and eGFR were the most significant predictors of primary outcome (aHR of 8.02 if eGFR <30 ml/min per 1.73 m2 [95% CI, 1.85 to 34.75]; aHR of 6.44 if eGFR 30 to <45 ml/min per 1.73 m2 [95% CI, 1.38 to 29.99]). Immunosuppressive therapy with rituximab was significantly associated with stabilization of disease progression. Conclusions: Detection of DNAJB9 is a useful diagnostic tool for diagnosing atypical forms of fibrillary GN. The outcomes for fibrillary GN are poor and progression to ESKD is influenced predominantly by the degree of kidney insufficiency at the time of diagnosis and male sex. Rituximab may help preserve kidney function for select patients with fibrillary GN. Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_11_04_CJN03870319.mp3

15 February 2014 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ALAmérico Harry López-Yglesias
Américo Harry López-Yglesias
XZXiaodan Zhao
Xiaodan Zhao
EQEllen Quarles
Ellen Quarles
MLMarvin A Lai
Marvin A Lai
TVTim VandenBos
Tim VandenBos
KSKelly D. Smith
Kelly D. Smith
Flagellin is a potent immunogen that activates the innate immune system via TLR5 and Naip5/6, and generates strong T and B cell responses. The adaptor protein MyD88 is critical for signaling by TLR5, as well as IL-1Rs and IL-18Rs, major downstream mediators of the Naip5/6 Nlrc4-inflammasome. In this study, we define roles of known flagellin receptors and MyD88 in Ab responses generated toward flagellin. We used mice genetically deficient in flagellin recognition pathways to characterize innate immune components that regulate isotype-specific Ab responses. Using purified flagellin from Salmonella, we dissected the contribution of innate flagellin recognition pathways to promote Ab responses toward flagellin and coadministered OVA in C57BL/6 mice. We demonstrate IgG2c responses toward flagellin were TLR5 and inflammasome dependent; IgG1 was the dominant isotype and partially TLR5 and inflammasome dependent. Our data indicate a substantial flagellin-specific IgG1 response was induced through a TLR5-, inflammasome-, and MyD88-independent pathway. IgA anti-FliC responses were TLR5 and MyD88 dependent and caspase-1 independent. Unlike C57BL/6 mice, flagellin-immunized A/J mice induced codominant IgG1 and IgG2a responses. Furthermore, MyD88-independent, flagellin-induced Ab responses were even more pronounced in A/J MyD88−/− mice, and IgA anti-FliC responses were suppressed by MyD88. Flagellin also worked as an adjuvant toward coadministered OVA, but it only promoted IgG1 anti-OVA responses. Our results demonstrate that a novel pathway for flagellin recognition contributes to Ab production. Characterization of this pathway will be useful for understanding immunity to flagellin and the rationale design of flagellin-based vaccines.